First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; William Harvey Research Institute, Queen Mary University of London, London, UK.
William Harvey Research Institute, Queen Mary University of London, London, UK; Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Atherosclerosis. 2020 Mar;296:11-17. doi: 10.1016/j.atherosclerosis.2020.01.015. Epub 2020 Jan 21.
Recent studies have unveiled an association between ADAMTS7 gene variation and coronary artery disease (CAD) caused by atherosclerosis. We investigated if the ADAMTS7 Serine214-to-Proline substitution arising from a CAD-associated variant affected angiogenesis, since neovascularization plays an important role in atherosclerosis.
ADAMTS7 knockdown in vascular endothelial cells (ECs) attenuated their angiogenesis potential, whereas augmented ADAMTS7-Ser214 expression had the opposite effect, leading to increased ECs migratory and tube formation ability. Proteomics analysis showed an increase in thrombospondin-1, a reported angiogenesis inhibitor, in culture media conditioned by ECs with ADAMTS7 knockdown and a decrease of thrombospondin-1 in media conditioned by ECs with ADAMTS7-Ser214 overexpression. Cleavage assay indicated that ADAMTS7 possessed thrombospondin-1 degrading activity, which was reduced by the Ser214-to-Pro substitution. The pro-angiogenic effect of ADAMTS7-Ser214 diminished in the presence of a thrombospondin-1 blocking antibody.
The ADAMTS7 Ser217-to-Pro substitution as a result of ADAMTS7 polymorphism affects thrombospondin-1 degradation, thereby promoting atherogenesis through increased EC migration and tube formation.
最近的研究揭示了 ADAMTS7 基因变异与动脉粥样硬化引起的冠心病(CAD)之间的关联。我们研究了源于 CAD 相关变异的 ADAMTS7 丝氨酸 214 至脯氨酸取代是否会影响血管生成,因为新生血管化在动脉粥样硬化中起着重要作用。
在血管内皮细胞(ECs)中敲低 ADAMTS7 会减弱其血管生成潜力,而增强的 ADAMTS7-Ser214 表达则会产生相反的效果,导致 ECs 的迁移和管形成能力增加。蛋白质组学分析表明,ADAMTS7 敲低的 ECs 条件培养基中血栓素-1(一种已知的血管生成抑制剂)增加,而 ADAMTS7-Ser214 过表达的 ECs 条件培养基中血栓素-1 减少。裂解实验表明 ADAMTS7 具有血栓素-1 降解活性,而 Ser214 至 Pro 取代会降低其活性。在存在血栓素-1 阻断抗体的情况下,ADAMTS7-Ser214 的促血管生成作用减弱。
ADAMTS7 多态性导致的 ADAMTS7 Ser217-to-Pro 取代会影响血栓素-1 的降解,从而通过增加 EC 迁移和管形成促进动脉粥样硬化形成。